Literature DB >> 3020327

Adrenocorticotropin reversal of experimental hemorrhagic shock is antagonized by morphine.

A Bertolini, S Guarini, W Ferrari, E Rompianesi.   

Abstract

ACTH-(1-24) dose-dependently improved cardiovascular function in rats and dogs subjected to experimental hemorrhagic shock, and intravenous dose of 160 and 100/microgram/kg, respectively, completely restoring arterial blood pressure and pulse amplitude. All saline-treated animals died within 30 min of bleeding, while all ACTH-treated animals were still alive at the end of the observation period (2 hr). The injection of ACTH-(1-24) also dramatically improved the respiratory function. Morphine, i.v. injected into rats at the dose of 2.5 mg/kg, antagonised the effect of ACTH-(1-24) to a greater or lesser degree, depending on the dose of peptide employed: at 160/microgram/kg, antagonism was complete, at 320/microgram/kg antagonism was only partial, while at 480/microgram/kg antagonism was almost completely overcome. These data further support the idea that melanocortins are physiological antagonists of opioids, and suggest that melanocortin peptides may prove to be rational and effective drugs in the treatment of hypovolemic shock.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020327     DOI: 10.1016/0024-3205(86)90188-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine.

Authors:  Aaron N A Verty; Malini E Singh; Iain S McGregor; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2003-04-17       Impact factor: 4.530

2.  Brain M3 muscarinic receptors are involved in the ACTH-induced reversal of hemorrhagic shock.

Authors:  S Guarini; S Tagliavini; C Bazzani; M Pasini; A Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

3.  ACTH-(1-24) restores blood pressure in acute hypovolaemia and haemorrhagic shock in humans.

Authors:  A Bertolini; S Guarini; W Ferrari; G Noera; C Massini; S Di Tizio
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Influence of ACTH-(1-24) on free radical levels in the blood of haemorrhage-shocked rats: direct ex vivo detection by electron spin resonance spectrometry.

Authors:  S Guarini; C Bazzani; G M Ricigliano; A Bini; A Tomasi; A Bertolini
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

5.  Involvement of the sympathetic nervous system in the cardiovascular effects of ACTH-(1-24) during hemorrhagic shock in rats.

Authors:  S Guarini; W Ferrari; A Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

6.  Dynorphin peptides: antagonists of melanocortin receptors.

Authors:  J M Quillan; W Sadée
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

7.  Role of neuronal and vascular Ca(2+)-channels in the ACTH-induced reversal of haemorrhagic shock.

Authors:  S Guarini; C Bazzani; A Bertolini
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Reversal of experimental hemorrhagic shock by dimethylphenylpiperazinium (DMPP).

Authors:  S Guarini; C Bazzani; S Tagliavini; A Bertolini; W Ferrari
Journal:  Experientia       Date:  1992-07-15

9.  Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock.

Authors:  F Squadrito; S Guarini; D Altavilla; G Squadrito; G M Campo; M Arlotta; C Quartarone; A Saitta; D Cucinotta; C Bazzani; M M Cainazzo; C Mioni; A Bertolini; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.